A detailed history of Stone Crest Wealth Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stone Crest Wealth Management, Inc. holds 4,925 shares of LLY stock, worth $4.36 Million. This represents 3.4% of its overall portfolio holdings.

Number of Shares
4,925
Previous 1,583 211.12%
Holding current value
$4.36 Million
Previous $1.23 Billion 262.08%
% of portfolio
3.4%
Previous 1.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $2.42 Million - $3.04 Million
3,342 Added 211.12%
4,925 $4.46 Billion
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $344,068 - $460,314
581 Added 57.98%
1,583 $1.23 Billion
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $526,240 - $620,368
1,002 New
1,002 $584 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Stone Crest Wealth Management, Inc. Portfolio

Follow Stone Crest Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone Crest Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone Crest Wealth Management, Inc. with notifications on news.